Online citations, reference lists, and bibliographies.
← Back to Search

Intestinal Tumorigenesis Is Suppressed In Mice Lacking The Metalloproteinase Matrilysin.

C. L. Wilson, K. Heppner, P. Labosky, B. Hogan, L. Matrisian
Published 1997 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Matrix metalloproteinases (MMPs) classically have been implicated in basement membrane destruction associated with late-stage tumor cell invasion and metastasis. However, recent studies have demonstrated that one MMP family member, matrilysin, is expressed in a high percentage of early-stage human colorectal tumors. We analyzed matrilysin expression in benign intestinal tumors from mice heterozygous for the ApcMin allele (Min/+) and found that the mRNA was induced in the majority (88%) of these adenomas. Protein was detected in the tumor cells, where, surprisingly, it was predominantly immunolocalized to the lumenal surface of dysplastic glands rather than the basement membrane or extracellular matrix. To address the role of matrilysin in Min intestinal tumorigenesis, we generated Min/+ mice deficient in this MMP by gene targeting and homologous recombination. The absence of matrilysin resulted in a reduction in mean tumor multiplicity in Min/+ animals of approximately 60% and a significant decrease in the average tumor diameter. Based on these findings, we conclude that matrilysin is a suppressor of the Min phenotype, possibly by functioning in a capacity independent of matrix degradation. These results argue for the use of MMP inhibitors in the treatment and prevention of early-stage colon cancer.
This paper references
10.1111/1523-1747.EP12317104
Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium.
U. Saarialho-Kere (1995)
10.1016/1357-2725(95)00121-2
Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions.
C. L. Wilson (1996)
Antibodies: A Laboratory Manual
E. Harlow (1988)
Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice.
X. Wang (1994)
10.1016/0092-8674(95)90015-2
The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia
M. MacPhee (1995)
10.1016/0003-2697(91)90534-Z
Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.
K. Guan (1991)
10.1007/978-3-642-61107-0
Attempts to Understand Metastasis Formation I
U. Günthert (1996)
Manipulating the mouse embryo: A laboratory manual
B. Hogan (1986)
10.1016/0003-2697(87)90021-2
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
P. Chomczyński (1987)
10.1016/0092-8674(93)90484-8
Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse
W. Dietrich (1993)
10.1126/SCIENCE.1350108
Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
L. Su (1992)
10.1083/JCB.125.3.681
Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression [published erratum appears in J Cell Biol 1996 Feb;132(4):following 752]
C. J. Sympson (1994)
10.1042/BJ3080211
Structural organization and chromosomal localization of the mouse collagenase type I gene.
M. Schorpp (1995)
10.1038/370555A0
Processing of tumour necrosis factor-α precursor by metalloproteinases
A. J. Gearing (1994)
Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.
S. Watson (1995)
Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy.
Clarke Ar (1995)
Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
J. P. Witty (1994)
10.1126/SCIENCE.2296722
A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.
A. Moser (1990)
10.1091/MBC.6.7.851
The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse.
C. L. Wilson (1995)
10.1126/science.7531366
Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix
N. Boudreau (1995)
10.1006/BBRC.1994.1751
Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.
H. Yamamoto (1994)
Wilson et al
X. Wang (1997)
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.
K. Heppner (1996)
Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor.
A. Kennedy (1996)
Wilson et al
W. F. Dietrich (1997)
10.1073/PNAS.90.5.1843
Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
C. Wolf (1993)
Attempts to understand metastasis formation. I. Metastasis-related molecules. Introduction.
U. Guenthert (1996)
Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
J. P. Witty (1995)
10.1083/JCB.108.5.1687
Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium
A. Ouellette (1989)
10.1042/BJ3100285
Diphtheria toxin endocytosis and membrane translocation are dependent on the intact membrane-anchored receptor (HB-EGF precursor): studies on the cell-associated receptor cleaved by a metalloprotease in phorbol-ester-treated cells.
M. Lanzrein (1995)
10.1016/b978-0-12-547150-3.50015-3
A Laboratory manual
M. Ashburner (1989)
Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase.
S. Shapiro (1992)
10.1016/0092-8674(95)90329-1
Suppression of intestinal neoplasia by DNA hypomethylation
P. Laird (1995)
10.1083/JCB.123.4.877
Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia
S. Kim (1993)
Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.
R. F. Jacoby (1996)
10.1038/336348A0
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes
S. Mansour (1988)
10.1038/359235A0
APC mutations occur early during colorectal tumorigenesis
S. Powell (1992)
10.1016/0092-8674(90)90186-I
A genetic model for colorectal tumorigenesis
E. Fearon (1990)
10.1101/SQB.1994.059.01.055
The adenomatous polyposis coli gene of the mouse in development and neoplasia.
W. Dove (1994)
10.1002/MC.2940100404
Expression and localization of matrix‐degrading metalloproteinases during colorectal tumorigenesis
K. Newell (1994)
10.1084/JEM.182.6.1777
Metalloproteinase-mediated release of human Fas ligand
N. Kayagaki (1995)
10.1091/MBC.6.10.1287
Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development.
J. P. Witty (1995)
10.1002/IJC.2910540415
Expression of MMP‐7(pump‐1) mRNA in human colorectal cancers
M. Yoshimoto (1993)
10.1016/0092-8674(92)90508-A
Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development
M. Rudnicki (1992)
10.1002/MC.2940040617
Expression and localization of the matrix metalloproteinase pump‐1 (MMP‐7) in human gastric and colon carcinomas
S. McDonnell (1991)



This paper is referenced by
10.1042/BJ20030582
Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity.
J. Mcintyre (2004)
10.1071/RD04110
Abundance of ADAM-8, -9, -10, -12, -15 and -17 and ADAMTS-1 in mouse uterus during the oestrous cycle.
J. Kim (2005)
10.1016/J.YJMCC.2006.09.020
Insights from knock-out models concerning postischemic release of TNFalpha from isolated mouse hearts.
J. Reil (2007)
10.1038/labinvest.3700552
Achaete-scute homolog-1 linked to remodeling and preneoplasia of pulmonary epithelium
X. Wang (2007)
10.1007/S00018-007-7388-0
Molecular basis of invasion in breast cancer.
E. McSherry (2007)
10.3760/CMA.J.ISSN.1009-9158.2011.04.024
Heart failure
许俊堂 (2011)
10.1158/0008-5472.CAN-06-4473
Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.
B. Fingleton (2007)
10.1385/1-59259-046-2:149
Models for gain-of-function and loss-of-function of MMPs. Transgenic and gene targeted mice.
L. Coussens (2001)
10.1007/978-1-59259-009-4_17
Angiogenesis and Prostate Cancer
I. B. Joseph (2001)
10.1200/JCO.2001.19.4.1118
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
H. Yamamoto (2001)
10.1053/GAST.2002.31885
Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells.
V. M. Díaz (2002)
Microarray-based gene expression analysis for the investigation of immunologically relevant processes in tumors
O. Schoor (2006)
10.1074/jbc.M507582200
The Rac Activator Tiam1 Is a Wnt-responsive Gene That Modifies Intestinal Tumor Development*
A. Malliri (2006)
10.1007/s13277-014-1748-9
Matrix metalloproteinase-13 expression in the progression of colorectal adenoma to carcinoma
A. A. Foda (2014)
10.1097/01.mlg.0000224368.58870.3c
Extracellular Matrix Metalloprotease Inducer Stimulates Fibroblast‐Mediated Tumor Growth In Vivo
E. Rosenthal (2006)
10.1002/(SICI)1097-0215(19980610)76:6<812::AID-IJC8>3.0.CO;2-0
Matrilysin‐specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model
S. Hasegawa (1998)
10.1146/ANNUREV.CELLBIO.17.1.463
How matrix metalloproteinases regulate cell behavior.
M. Sternlicht (2001)
10.1200/JCO.2000.18.5.1135
Matrix metalloproteinases: biologic activity and clinical implications.
A. Nelson (2000)
10.1007/BF02826217
Induction of matric metalloprotease-7 is common in mucinous ovarian tumors including early stage disease
K. Shigemasa (2000)
10.1016/S0002-9440(10)64318-0
Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium.
J. McGuire (2003)
10.1016/J.BCP.2005.07.023
Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors.
K. Cheng (2005)
10.1007/978-1-84628-947-7_2
Biology of Colorectal Cancer Liver Metastases
C. Wray (2009)
Rac 1 mutations produce aberrant epithelial differentiation in the developing and adult mouse small intestine
T. Stappenbeck (2000)
Carcinoma Poor Prognosis in Human Esophageal Squamous Cell Association of Matrilysin Expression with Recurrence and Updated
Hiroyuki Yamamoto (1999)
10.1016/S0002-9440(10)64685-8
The role of metalloelastase in immune complex-induced acute lung injury.
R. Warner (2001)
10.1002/1097-4652(2001)9999:9999<::AID-JCP1048>3.0.CO;2-W
Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co‐culture with fibroblasts and upon induction of decorin expression
E. Schönherr (2001)
10.1038/nrc2541
Toll-like receptors and cancer
S. Rakoff-Nahoum (2009)
Crosstalk between Insulin and Wnt Signaling Pathways
Jane Sun (2010)
Expression, activation, and regulation of matrix metalloproteinase 2 (MMP-2) in the bovine corpus luteum
Bo Zhang (2002)
10.1007/s10238-012-0212-7
Knockdown of MMP-7 inhibits cell proliferation and enhances sensitivity to 5-fluorouracil and X-ray irradiation in colon cancer cells
W. Zhang (2012)
BASIC SCIENCE REVIEW
J. Myers (2002)
10.1111/j.1349-7006.2006.00190.x
Mouse models of gastrointestinal tumors
M. Taketo (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar